Vaccine development in the SARS-CoV-2 pandemic: a balancing act on accuracy and speed.
作者信息
Linares-Fernández Sergio, Raguindin Peter Francis
机构信息
Laboratoire de Biologie Tissulaire et Ingénierie Thérapeutique, Centre National de la Recherche Scientifique and Université Claude Bernard Lyon 1, Lyon, France.
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
出版信息
Int J Public Health. 2020 Nov;65(8):1433-1434. doi: 10.1007/s00038-020-01511-2. Epub 2020 Oct 13.
Abstract
摘要
相似文献
1
Vaccine development in the SARS-CoV-2 pandemic: a balancing act on accuracy and speed.2019冠状病毒病大流行期间的疫苗研发：准确性与速度之间的平衡之举
Int J Public Health. 2020 Nov;65(8):1433-1434. doi: 10.1007/s00038-020-01511-2. Epub 2020 Oct 13.
2
Vaccine safety - is the SARS-CoV-2 vaccine any different?疫苗安全性 - SARS-CoV-2 疫苗有何不同？
Hum Vaccin Immunother. 2021 May 4;17(5):1322-1325. doi: 10.1080/21645515.2020.1829414. Epub 2020 Dec 3.
3
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
4
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19（Sars-Cov-2）的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
5
Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.中亚地区 SARS-CoV-2 传播的监测指标：纵向趋势分析。
J Med Internet Res. 2021 Feb 3;23(2):e25799. doi: 10.2196/25799.
6
Targets and strategies for vaccine development against SARS-CoV-2.针对 SARS-CoV-2 的疫苗研发的靶点和策略。
Biomed Pharmacother. 2021 May;137:111254. doi: 10.1016/j.biopha.2021.111254. Epub 2021 Jan 28.
7
Identification of Generalized Peptide Regions for Designing Vaccine Effective for All Significant Mutated Strains of SARS-CoV-2.鉴定用于设计针对所有 SARS-CoV-2 重要突变株有效的疫苗的通用肽区域。
Comb Chem High Throughput Screen. 2022;25(3):414-428. doi: 10.2174/1386207324666210601122820.
8
Adapting Serosurveys for the SARS-CoV-2 Vaccine Era.适应新冠病毒疫苗时代的血清学调查。
Open Forum Infect Dis. 2021 Dec 23;9(2):ofab632. doi: 10.1093/ofid/ofab632. eCollection 2022 Feb.
9
Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).基于免疫信息学设计针对严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 的基于表位的亚单位疫苗。
Immunobiology. 2020 May;225(3):151955. doi: 10.1016/j.imbio.2020.151955. Epub 2020 May 11.
10
SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.中东和北非地区的 SARS-CoV-2 监测：纵向趋势分析。
J Med Internet Res. 2021 Jan 15;23(1):e25830. doi: 10.2196/25830.
引用本文的文献
1
Advancements in the development of nucleic acid vaccines for syphilis prevention and control.核酸疫苗在梅毒防控中的研发进展。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2234790. doi: 10.1080/21645515.2023.2234790.
2
Associations of Underlying Health Conditions With Anxiety and Depression Among Outpatients: Modification Effects of Suspected COVID-19 Symptoms, Health-Related and Preventive Behaviors.基础健康状况与门诊患者焦虑和抑郁的关联：疑似 COVID-19 症状、与健康相关行为和预防行为的调节作用。
Int J Public Health. 2021 Jun 23;66:634904. doi: 10.3389/ijph.2021.634904. eCollection 2021.
3
DNA vaccines against COVID-19: Perspectives and challenges.针对 COVID-19 的 DNA 疫苗：观点与挑战。
Life Sci. 2021 Feb 15;267:118919. doi: 10.1016/j.lfs.2020.118919. Epub 2020 Dec 19.
本文引用的文献
1
Evolution of the COVID-19 vaccine development landscape.新冠疫苗研发格局的演变。
Nat Rev Drug Discov. 2020 Oct;19(10):667-668. doi: 10.1038/d41573-020-00151-8.
2
Immunology of COVID-19: Current State of the Science.COVID-19 的免疫学：科学现状。
Immunity. 2020 Jun 16;52(6):910-941. doi: 10.1016/j.immuni.2020.05.002. Epub 2020 May 6.
3
COVID-19 vaccine design: the Janus face of immune enhancement.COVID-19 疫苗设计：免疫增强的两面性。
Nat Rev Immunol. 2020 Jun;20(6):347-348. doi: 10.1038/s41577-020-0323-4. Epub 2020 Apr 28.
4
The potential danger of suboptimal antibody responses in COVID-19.新冠肺炎中抗体反应欠佳的潜在危险。
Nat Rev Immunol. 2020 Jun;20(6):339-341. doi: 10.1038/s41577-020-0321-6.
5
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.基于 SARS-CoV 免疫学研究的 COVID-19 冠状病毒（SARS-CoV-2）潜在疫苗靶点的初步鉴定。
Viruses. 2020 Feb 25;12(3):254. doi: 10.3390/v12030254.
6
An interactive web-based dashboard to track COVID-19 in real time.一个基于网络的交互式仪表盘，用于实时追踪新冠病毒。
Lancet Infect Dis. 2020 May;20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19.
7
Emerging Technologies for Low-Cost, Rapid Vaccine Manufacture.新兴技术助力低成本、快速疫苗生产。
Biotechnol J. 2019 Jan;14(1):e1800376. doi: 10.1002/biot.201800376. Epub 2018 Dec 10.
8
The complexity and cost of vaccine manufacturing - An overview.疫苗生产的复杂性与成本——概述
Vaccine. 2017 Jul 24;35(33):4064-4071. doi: 10.1016/j.vaccine.2017.06.003. Epub 2017 Jun 21.
Zotero 插件